Analyst Consensus
- Current Price
- 337.60 $
- Target (Low)
- 200.00 $
- Target (Mean)
- 352.77 $
- Target (High)
- 427.00 $
- Recommendation
- Buy
- Number of Analysts
- 30
Recommendation Distribution
Recommendation Distribution| Strong Buy | 4 |
|---|
| Buy | 10 |
|---|
| Hold | 18 |
|---|
| Sell | 2 |
|---|
| Strong Sell | 1 |
|---|
Key Ratios
- Net Profit Margin
- 21.0%
- Operating Margin
- 33.8%
- Gross Margin
- 71.4%
- Return on Equity (ROE)
- 101.3%
- Return on Assets (ROA)
- 8.3%
- Revenue Growth
- 5.8%
- Earnings Growth
- 4.4%
- Debt/Equity
- 623.75
- Current Ratio
- 1.26
- Beta
- 0.42
Recent Rating Changes
Recent Rating Changes| Date | Firm | Change |
|---|
| Jun 16, 2026 | Mizuho | Neutral → Neutral |
| Jun 10, 2026 | Morgan Stanley | Equal-Weight → Equal-Weight |
| May 14, 2026 | Piper Sandler | Overweight → Overweight |
| May 4, 2026 | Guggenheim | Neutral → Neutral |
| May 1, 2026 | Truist Securities | Hold → Hold |
| Apr 21, 2026 | Canaccord Genuity | Hold |